These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9507238)

  • 1. Hepatic cholesterol metabolism in experimental nephrotic syndrome.
    al-Shurbaji A; Humble E; Rudling M; Lindenthal B; Berglund L
    Lipids; 1998 Feb; 33(2):165-9. PubMed ID: 9507238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat.
    Golper TA; Feingold KR; Fulford MH; Siperstein MD
    J Lipid Res; 1986 Oct; 27(10):1044-51. PubMed ID: 3794548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
    Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
    Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
    Vaziri ND; Liang K
    Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats.
    Thabet MA; Challa A; Chan JC; Pandak WM; Heuman DM; Vlahcevic ZR
    Kidney Int; 1993 Oct; 44(4):789-94. PubMed ID: 8258956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired renal mevalonate metabolism in nephrotic syndrome: a stimulus for increased hepatic cholesterogenesis independent of GFR and hypoalbuminemia.
    Golper TA; Swartz SH
    Metabolism; 1982 May; 31(5):471-6. PubMed ID: 7078427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
    Vaziri ND; Sato T; Liang K
    Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis.
    Vaziri ND; Liang KH
    Kidney Int; 1995 Dec; 48(6):1979-85. PubMed ID: 8587261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome.
    Tovar AR; Murguía F; Cruz C; Hernández-Pando R; Aguilar-Salinas CA; Pedraza-Chaverri J; Correa-Rotter R; Torres N
    J Nutr; 2002 Sep; 132(9):2562-9. PubMed ID: 12221209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K; Vaziri ND
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis.
    al-Shurbaji A; Berglund L; Berge RK; Cederblad G; Humble E
    Lipids; 1997 Aug; 32(8):847-52. PubMed ID: 9270976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing hepatic cholesterol 7alpha-hydroxylase reduces plasma cholesterol concentrations in normocholesterolemic and hypercholesterolemic rabbits.
    Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Tint GS; Parker TS; Roberts J; Batta AK; Chen TS; Zhao Z; Kong X
    Hepatology; 1996 Oct; 24(4):882-7. PubMed ID: 8855192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute P-407 administration to mice causes hypercholesterolemia by inducing cholesterolgenesis and down-regulating low-density lipoprotein receptor expression.
    Leon C; Wasan KM; Sachs-Barrable K; Johnston TP
    Pharm Res; 2006 Jul; 23(7):1597-607. PubMed ID: 16783477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gender on hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and LDL receptor in hereditary analbuminemia.
    Shin Y; Vaziri ND; Willekes N; Kim CH; Joles JA
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E993-8. PubMed ID: 16030068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside-nephrotic rats.
    Moritomo Y; Hirano T; Ebara T; Kurokawa M; Naito H; Furukawa S; Nagano S
    Nephron; 1994; 67(2):218-25. PubMed ID: 8072613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND; Liang K; Azad H
    J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.
    al-Shurbaji A; Skorve J; Berge RK; Rudling M; Björkhem I; Berglund L
    Arterioscler Thromb; 1993 Nov; 13(11):1580-6. PubMed ID: 8218098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
    Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G
    Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND; Liang KH
    Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.